 Flow cytometric evaluation chemosensitive chemoresistant head neck tumors patients head neck squamous carcinoma clinical response induction chemotherapy survival advantage patients diploid tumors survival advantage patients aneuploid tumors study DNA content patients undergone induction chemotherapy part clinical protocols correlation patients diploid tumors patients clinical response patients stage III tumors disease-free survival stage IV patients addition DNA content information ability response correlation DNA content response chemotherapy addition group patients diploid DNA content survival advantage DNA content information prediction clinical outcome patients induction chemotherapy